Search

everythinglearnresearchcommunity

for

Search:↓

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

The method accurately measures testosterone metabolites with high sensitivity and low environmental impact.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

The mouse model helps study and develop treatments for radiation-induced saliva reduction.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Overt hyperthyroidism is the most common thyroid disorder, especially in women.

Topical radioprotectors can reduce radiation-induced hair loss.

The method effectively detects banned substances in urine for sports antidoping.

Nanoparticles can effectively deliver spironolactone to hair follicles for treating alopecia and acne.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Steroid hormone binding in rat skin varies with pH, heat, and hair cycle phases.

A new, less toxic and more efficient method to create the anti-baldness compound RU58841 was developed in 2014.

DAB labeling effectively identifies collagen type III and PDGFR in horse skin, but may show false positives.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

A man had temporary hair loss from radiation during a medical procedure but regrew his hair after treatment with minoxidil lotion.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Ovarian vein sampling can effectively locate ovarian tumors when imaging is unclear.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.